<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Tasigna from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Tasigna news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 00:26:45 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Tasigna" rel="self" type="application/rss+xml" />

	
<item><title>NICE says pharma should help pay for leukemia drugs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037526&amp;HITNO=0&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037526&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537132762%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037526&amp;HITNO=0&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037526&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537132762%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Medical Marketing And Media:</description></item>
<item><title>CORRECT: FDA: Low Response Rate Seen With Proposed Drug Omapro</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032431&amp;HITNO=1&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032431&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534648662%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032431&amp;HITNO=1&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032431&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534648662%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Morningstar.com:</description></item>
<item><title>CORRECT: FDA: Low Response Rate Seen With Proposed Drug Omapro</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032402&amp;HITNO=2&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032402&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534639444%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032402&amp;HITNO=2&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032402&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534639444%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FOXNews.com:</description></item>
<item><title>UPDATE: FDA: Low Response Rate Seen With Proposed Drug Omapro</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032401&amp;HITNO=3&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032401&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534639332%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032401&amp;HITNO=3&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032401&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534639332%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FOXNews.com:</description></item>
<item><title>CORRECT: FDA: Low Response Rate Seen With Proposed Drug Omapro</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032380&amp;HITNO=4&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032380&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534635716%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032380&amp;HITNO=4&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032380&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534635716%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FOXBusiness.com:</description></item>
<item><title>UPDATE: FDA: Low Response Rate Seen With Proposed Drug Omapro</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032379&amp;HITNO=5&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032379&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534635615%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032379&amp;HITNO=5&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032379&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534635615%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FOXBusiness.com:</description></item>
<item><title>CORRECT: FDA: Low Response Rate Seen With Proposed Drug Omapro</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032334&amp;HITNO=6&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032334&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534606823%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032334&amp;HITNO=6&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032334&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534606823%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Lloyd's:</description></item>
<item><title>CORRECT: FDA: Low Response Rate Seen With Proposed Drug Omapro</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032302&amp;HITNO=7&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032302&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534592461%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032302&amp;HITNO=7&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032302&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534592461%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Nasdaq:</description></item>
<item><title>UK says Novartis, Bristol cancer drugs too costly</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032559&amp;HITNO=8&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032559&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534704879%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032559&amp;HITNO=8&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032559&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534704879%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Reuters UK:</description></item>
<item><title>NICE warns industry on cost-effectiveness</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036369&amp;HITNO=9&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036369&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536587222%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036369&amp;HITNO=9&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036369&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536587222%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmafocus:</description></item>
<item><title>UK says Novartis, Bristol cancer drugs too costly</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032137&amp;HITNO=10&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032137&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534518266%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032137&amp;HITNO=10&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032137&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534518266%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Sharenet:</description></item>
<item><title>UK Body Says Novartis, Bristol Cancer Drugs Too Expensive</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036867&amp;HITNO=11&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036867&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536805529%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036867&amp;HITNO=11&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036867&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536805529%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Lloyd's:</description></item>
<item><title>UK Body Says Novartis, Bristol Cancer Drugs Too Expensive (DJ)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036580&amp;HITNO=12&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036580&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536668363%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036580&amp;HITNO=12&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036580&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536668363%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Easy Bourse:</description></item>
<item><title>UK Body Says Novartis, Bristol Cancer Drugs Too Expensive</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036474&amp;HITNO=13&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036474&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536630247%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036474&amp;HITNO=13&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036474&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536630247%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Nasdaq:</description></item>
<item><title>How Much Should Cancer Drugs Cost?</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038075&amp;HITNO=14&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038075&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537465936%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038075&amp;HITNO=14&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tasigna&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038075&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537465936%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Wall Street Journal Online:</description></item>
</channel></rss>